Drug Profile


Alternative Names: MENT

Latest Information Update: 11 Aug 2008

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Bayer Schering Pharma
  • Class Anabolic steroids; Contraceptives; Estrenes; Progesterone congeners; Small molecules
  • Mechanism of Action Testosterone congener stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Andropause

Most Recent Events

  • 13 Jan 2004 A study has been added to the adverse events and Mens Health therapeutic trials sections
  • 05 Nov 2002 Phase-II clinical trials in Andropause in Europe (Topical)
  • 05 Aug 2001 Phase-I clinical trials for Andropause in Europe (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top